EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... - PipelineReview.com (press release)
April 16, 2007| EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... PipelineReview.com (press release), Spain - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
AtheroGenics to Report First Quarter 2007 Financial Results on ... - Web Services Journal
April 16, 2007| AtheroGenics to Report First Quarter 2007 Financial Results on ... Web Services Journal, NJ - ... of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. ... |
Abbott Opens New Biotechnology Manufacturing Facility In Puerto - Pharmaceutical Online (press release)
April 16, 2007| Abbott Opens New Biotechnology Manufacturing Facility In Puerto Pharmaceutical Online (press release), PA - ABL is now the main production facility for HUMIRA, the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), ... |
AtheroGenics to Report First Quarter 2007 Financial Results on ... - Genetic Engineering News (press release)
April 16, 2007| AtheroGenics to Report First Quarter 2007 Financial Results on ... Genetic Engineering News (press release), NY - ... of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. ... |
EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... - PharmaLive.com (press release)
April 16, 2007| EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... PharmaLive.com (press release), PA - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... - Drug Newswire (press release)
April 16, 2007| EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... Drug Newswire (press release), CT - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... - PR Newswire (press release)
April 16, 2007| EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in ... PR Newswire (press release), NY - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |